HopeStage
Back to all studies
RecruitingNCT05580211

Studying brainstem stimulation and awareness of illness in schizophrenia

About this titleRead the official source — NCT05580211
Device studyAges 18+Canada
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 3, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
34
Sponsor
Scion NeuroStim
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
Canada
Age range
Over 18 Years
Official registry ID
NCT05580211
Official title
Show the full official title

The Clinical and Functional Imaging Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia

Recruitment & locations

Currently recruiting

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Scion NeuroStim.

Who can participate?

This study is for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies